The FDA Group has introduced an innovative solution to compliance auditing in the life sciences sector with the launch of the Audit Intelligence Compliance Assistant, or AICA. This AI-powered platform is designed specifically for pharmaceutical and biologic companies, significantly reducing the time needed to audit quality management system (QMS) documentation.
Streamlined Auditing Process
Traditionally, compliance audits can take weeks, pulling resources away from critical tasks. AICA changes this paradigm by allowing quality and regulatory professionals to upload extensive QMS documentation—including policies, procedures, and work instructions—and select applicable FDA regulations for auditing. Within hours, the platform provides a comprehensive gap analysis that highlights non-conformance areas, leveraging the power of AI to analyze all uploaded documents instead of relying on outdated sampling techniques.
Addressing Long-Standing Challenges
Nicholas Capman, President and CEO of The FDA Group, emphasizes the long-standing dilemma faced by quality leaders: the need for thorough compliance audits versus the disruption they cause to daily operations. AICA offers a third option. It is a sophisticated AI trained by seasoned auditors, capable of delivering rapid and thorough analyses of compliance gaps before regulators can intervene, thus minimizing operational disruptions.
Expert-Driven AI Training
What sets AICA apart from general-purpose AI tools is its training methodology. It was developed by more than 15 experienced FDA and ISO auditors who focused on interpreting regulations as they are applied in real-world pharmaceutical environments. This expertise ensures that AICA understands not just the regulations, but their practical implications during inspections.
Comprehensive Regulatory Support
The platform currently supports auditing against key regulations such as 21 CFR Parts 11, 211, and 600, with plans to incorporate additional regulations like 21 CFR Parts 50, 54, 56, 58, 312, 314, and 320, as well as ICH guidance documents. Each regulation is meticulously mapped at both section and subsection levels to ensure thorough compliance checks.
Human Oversight in AI Findings
AICA employs a human-in-the-loop approach, reinforcing the importance of human oversight in compliance auditing. Every observation generated by the AI must be reviewed by a qualified quality professional prior to final report generation. This allows users to modify findings based on their organizational context and institutional knowledge.
Detailed Compliance Reporting
The platform generates thorough compliance reports that include relevant regulatory citations, prioritized observations, and suggested corrective actions. Additionally, it offers executive-level dashboards featuring heat maps that provide visibility across the entire QMS. This functionality enhances clarity and decision-making for stakeholders at all levels of the organization.
Robust Security Features
AICA is built on EPAM DIAL, an open-source GenAI Enterprise Platform, and is hosted on Microsoft Azure servers in the United States. With enterprise-grade encryption, role-based access controls, and isolated document storage, AICA ensures that customer data remains secure. Organizations can choose to deploy AICA on private cloud infrastructure if they have heightened security requirements.
Collaboration for Impact
The partnership between The FDA Group and EPAM Systems highlights the potential of applied AI in regulated industries. By merging EPAM’s data science and engineering capabilities with The FDA Group’s regulatory expertise, AICA addresses real operational challenges faced by life sciences companies of all sizes.
Looking Ahead
AICA is now available for life sciences organizations eager to enhance their compliance auditing processes. Companies interested in experiencing its capabilities can schedule a demo to explore how AICA can transform their quality management systems.
Key Takeaways
- AICA reduces auditing time from weeks to hours.
- It analyzes 100% of QMS documentation, ensuring comprehensive compliance checks.
- AICA was trained by experienced auditors for real-world applicability.
- Human oversight is integral to the compliance auditing process.
- The platform includes robust security features and customizable deployment options.
In conclusion, AICA represents a significant advancement in compliance auditing within the life sciences sector. By leveraging AI technology and expert insights, it empowers organizations to identify compliance gaps swiftly and accurately, enhancing operational efficiency while maintaining regulatory integrity. This innovation not only streamlines processes but also sets a new standard for compliance auditing in the industry.
Read more → www.jsonline.com